Form 4: Cystic Fibrosis Foundation Acquires and Disposes of BiomX Inc. Shares and Warrants

The Cystic Fibrosis Foundation reports acquiring and disposing of BiomX Inc. common stock and warrants, impacting their beneficial ownership.

Summary

• On May 15, 2024, the Cystic Fibrosis Foundation engaged in transactions involving BiomX Inc. (PHGE) securities.
• The foundation acquired 4,778,265 shares of common stock at a price of $0.001 per share.
• Simultaneously, the foundation disposed of 4,778,265 shares of common stock.
• Following these transactions, the foundation's beneficial ownership stands at 9,330,580 shares.
• The foundation also acquired a warrant to purchase 4,778,265 shares of common stock at $0.001.
• The warrant was initially exercisable on February 27, 2023, but became fully exercisable on May 15, 2024, and does not expire.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing detailing transactions. It doesn't inherently convey positive or negative sentiment, but rather reports factual changes in ownership.

Industry Context

This filing reflects changes in beneficial ownership of BiomX Inc., a company in the biotechnology sector. Such filings are common and provide transparency into the holdings of major shareholders.

Stakeholder Impact

• The change in ownership may be of interest to shareholders of BiomX Inc.

Key Dates